Invicro - Central Nervous System (CNS)

Invicro has spent 20 years specializing in neuroscience imaging solutions for preclinical, early phase and late phase clinical studies. Our capabilities span from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials. We have expertise in coordinating worldwide multi-center imaging studies, and providing management and oversight of radiotracer supply for both commercial and non-commercially available agents. Solutions include: histopathology, preclinical imaging, phase 0-iv imaging support, clinical imaging core lab, advanced image analytics including novel IQ analytics suite, quantitative imaging endpoints.